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Materials and Methods 
 Neurosurgical tissue acquisition. We receive regular acute neurosurgical brain tissue 
donations at the Allen Institute for Brain Science. These samples are excised as a matter of 
course to access the epileptic focus or tumor. All samples used in this study were derived from 
temporal cortex, most frequently middle temporal gyrus.  These samples are immersed in pre-
carbogenated ACSF.7 (recipe below), transported to the Allen Institute for Brain Science rapidly 
with carbogenation, and sliced on a compresstome (Precisionary Instruments, Greenville NC 
USA, catalog #VF-200) into 350 μm slices, and continuously carbogented in ACSF.7 until 
dissociation.   
 Bulk tissue ATAC-seq. We harvested MTG tissue slices after bubbling in ACSF.7 for up 
to 16 hours, and we treated with NeuroTrace 500/525 (catalog # N21480 from ThermoFisher 
Scientific, 1/100 in ACSF.7) to highlight layered cortex structure.  With fine forceps we trimmed 
away white matter and meningeal tissues, and then dissected layers 1-6 into six different low-
binding Eppendorf 1.5 mL tubes (MilliporeSigma catalog # Z666548) under a fluorescence 
microscope as in Hodge et al. (8). We discarded supernatant and replaced with 50-100 μL of 
Nextera DNA library reaction (#FC-121-1031 from Illumina) containing 0.1% IGEPAL-630 (NP-
40 alternative), and then pipetted up and down vigorously 25-50 times using a P200 pipette, and 
then incubated at 37˚C for one hour for transposition.  We then added 1 mL of Homogenization 
Buffer (recipe below) to quench the reaction, pelleted samples at 1000g for 5 minutes at 4˚C, 
resuspended samples in 1 mL fresh homogenization buffer, released nuclei from samples using 
~10-15 strokes of a loose-fitting dounce pestle followed by ~10-15 strokes of a tight-fitting 
dounce pestle, then filtered nuclei with a 70 μm nylon mesh strainer, and pelleted nuclei at 
1,000xg for 10 minutes at 4˚C.  To stain, we resuspended nuclei in 500 μL of ice-cold Blocking 
Buffer (recipe below) containing 1/500 PE-NeuN antibody (MilliporeSigma catalog # 
FCMAB317PE) and 1 μg/mL 4’-diamino-phenylindazole (DAPI, MilliporeSigma catalog # 
D9542), rocked samples for 30 minutes at 4˚C, then pelleted at 1,000xg for 5 minutes at 4˚C, 
and finally resuspended samples in 500 μL fresh ice-cold blocking buffer before sorting cells on 
a FacsARIA III.   
 Using scatter profiles to eliminate debris and doublets, we sorted bulk samples as 
DAPI+NeuN+ from layers 1-6, or as DAPI+NeuN- from layer 1 and layer 5 samples, at 5,000-
10,000 cells per sample, into 200 μL of blocking buffer in low-binding Eppendorf 1.5 mL tubes.  
We pelleted sorted nuclei at 1,000xg for 10 minutes at 4˚C, followed by resuspension in 50 μL 
Proteinase K Cleanup Buffer (recipe below) and 37˚C incubation for 30 minutes, and then 
freezing at -20˚C until library prep and sequencing.   
 For library prep, we purified tagmented DNA with 1.8x vol/vol Ampure XP beads 
(Beckman-Coulter catalog # A63881), eluted DNA in 11 μL and then PCR-amplified with 
Nextera Index kit primers (#FC-121-1012 from Illumina) using KAPA HiFi HotStart ReadyMix 
(KAPA Biosystems #KK2602) in a 30 μL reaction (72° 3:00, 95° 1:00, cycle 17x [98° :20, 65° 
:15, 72° :15], 72° 1:00).  We purified PCR products using 1.8x Ampure XP beads, and quantified 
libraries using Agilent BioAnalyzer High Sensitivity DNA Chips (catalog # 5067-4626). Then 
sample libraries were pooled evenly and sequenced with paired-end 50bp reads either on 
Illumina MiSeq (Allen Institute) or NextSeq machines (SeqMatic, Fremont CA USA).  We 
processed fastq files as described below.   
 Single nuclear ATAC-seq.  We modified the single nuclear ATAC-seq workflow from the 
bulk sample workflow in several ways, most notably performing transposition reactions following 
sorting rather than prior to sorting, and omitting DAPI except for non-neuronal samples (due to 
the uncertainty of DAPI possibly interfering with transposition).  
We collected and dissected specific MTG tissue layers as for bulk samples, but we 
immediately dounced the layers to release nuclei, and then stained in blocking buffer containing 
PE-NeuN antibody but not DAPI. We sorted single NeuN+ nuclei from each layer into wells of a 
96-well plate, using scatter profiles to exclude debris and doublets. We confirmed single 
nucleus-to-event correspondence by test-sorting single NeuN+ events into flat-bottom 96 well 
plates with 40 μL blocking buffer containing DAPI followed by pelleting 1 min at 3,000xg and 
microscopic examination. These tests routinely yielded >95% single nucleus-filled wells and 
undetectable doublets. In the cases where glial cells were sorted, we first sorted neurons from 
the sample using PE-NeuN+ staining, and then treated with DAPI (1 μg/μL) for 1-2 minutes prior 
to sorting glial cells as DAPI+NeuN- events.   
 We sorted single NeuN+ cells into 1.5 μL of Nextera Tn5 transposition reaction (0.6 μL 
Tn5 enzyme, 0.75 μL tagmentation buffer, 0.15 μL 1% IGEPAL CA-630) in Eppendorf semi-
skirted 96-well plates (MilliporeSigma catalog # EP0030129504).  Immediately following sorting 
we briefly centrifuged plates, vortexed briefly, centrifuged plates again, and then incubated 
plates at 37˚C for 30 minutes for transposition. After transposition we added 0.6 μL Proteinase K 
Cleanup Buffer (recipe below), vortexed briefly and centrifuged, and incubated at 40˚C for an 
additional 30 minutes, then froze plates until library prep.  Library prep for single nuclear 
samples was the same as for bulk samples, except we increased the number of amplification 
cycles from 17 to 22 cycles due to the lower input DNA content.   
 Bulk ATAC-seq sample clustering.  We called peaks on all 39 bulk samples from 5 
independent specimens using MACS2 (26), and then used DiffBind (27) to identify 73,742 
differential peaks for all contrasts among the sample types (sort strategies and specimens).  Of 
these, 1,524 distinguished experimental specimens and were discarded for clustering.  With 
72,218 remaining peaks found specifically to discriminate any pairwise combinations of sort 
strategies, we reanalyzed correlation among bulk samples using reads in these peaks.  This 
correlation matrix revealed grouping of non-neuronal samples, upper layer neuronal samples, 
and lower layer neuronal samples (Fig. S2C).  One sample was omitted from this analysis 
(H17.03.009 L1 NeuN+) because this sample appeared intermediate between NeuN+ and 
NeuN- cells, likely due to a sorting error.   
 ATAC-seq data preprocessing and quality control. We retrieved sample-specific fastq 
files using standard built-in Illumina de-indexing protocols.  We mapped each fastq file to human 
genome reference hg38 patch 7 using bowtie2 and the flags --no-mixed --no-discordant -X 2000 
to generate sample-specific bam files, which we then filtered for low-quality mappings, 
secondary mappings, and unmapped reads using samtools view -q 10 -F 256 -F 4, and then 
filtered for duplicate reads using samtools rmdup.  We then converted these filtered reads bam 
files to bed files using bedTools bamToBed for quality control calculations of mean ENCODE 
overlap and TSS enrichment score.  For mean ENCODE overlap we converted bed files to 
fragment format, and assessed the percentage of unique fragments that overlap with ENCODE 
project DNaseI hypersensitivity peaks from adult human frontal cortex (studies ENCSR000EIK 
and ENCSR000EIY, 20, 28) using bedTools intersectBed (29), and took the mean of these two 
numbers.  For TSS enrichment score we used the published technique of Chen et al (30).  This 
technique sums the overlap of reads in 2kb windows surrounding all human TSSs, then 
segments this 2kb window into 40 50-bp bins, then normalizes the summed read counts to the 
outside four bins (first and last two), and finally reports the TSS enrichment score as the 
maximum height of that normalized read count graph.  We noticed that this technique worked 
well for all bulk samples but gave spurious abnormally high scores for some single nuclei having 
low read count; as a result we made the modification to set TSS enrichment score to 1 (no 
enrichment) for single nuclei having fewer than 500 reads or TSSs calculated to be greater than 
20 (likely spurious events).   
 We used these quality control metrics to filter out low quality nuclei (ENCODE overlap < 
15% AND TSS score < 4, Fig. S3).  Additionally we filtered out nuclei having fewer than 10,000 
unique read pairs, since we require this many reads for our clustering approach.  Of 3,660 initial 
cells we confined analysis to 2,858 high quality nuclei for clustering.    
 Clustering single nuclei:  bootstrapped clustering. We clustered single nuclei using 
extended fragment Jaccard distance calculations among cells as implemented by the lowcat 
package (10). To accomplish this, we first excluded reads on chromosomes X, Y, and M to 
prevent differential chromosome-biased clustering.  Then we randomly downsampled to 10,000 
unique fragments per nucleus, and then these fragments were extended to a regularized length 
of 1,000 bp with the same center. With these lists of extended fragments we next calculated the 
Jaccard similarity score for each nucleus pair, defined as the quotient of the intersecting 
extended fragment number, by the extended fragment union number. Then we calculated 
Jaccard distances among all nucleus pairs as 1 minus Jaccard similarity score.   
Finally this 2,858 x 2,858 Jaccard distance matrix was dimensionality reduced to a 2858 
x 29 matrix of principal component variates, using axes 2 through 30 calculated by princomp in 
the R base stats package. We omitted principal component 1 because it was highly correlated 
to quality control metrics, suggesting that this axis primarily reflected library quality (Fig. S4B-D). 
Principal components beyond 30 contain little cell type information, so excluding them 
represents a de-noising step (Fig. S4A). These resulting 29 PCs are used to call nuclear 
clusters and to visualize them using tSNE.   
To call cell clusters on this 2,858 x 29 principal component matrix, we bootstrapped an 
iterated PCA then Jaccard-Louvain clustering technique using k = 15 nearest neighbors (after 
testing k = 5,10,15,20, and finding 15 to give best visual separation of clusters on tSNE 
coordinates).  We repeated each bootstrapping round 200 times, each time including only 80% 
(2,286) of the nuclei, then performing PCA and using components 2 through 30 for Jaccard-
Louvain clustering.  Finally we tabulated the frequency with which each nucleus co-clusters with 
every other nucleus.  This co-clustering frequency matrix was then hierarchically clustered by 
Euclidean distances, and 27 cell type clusters were called by manually cutting the tree using 
idendr0 (https://github.com/tsieger/idendr0) to represent visually apparent co-clustered blocks of 
nuclei (Fig. S4D, left).  Manual tree-cutting outperformed automatic tree cutting with cutree in 
the R stats package using either branch height or cluster number specified, likely since clusters 
have nonuniform separation and tightness.   
Next we repeated this process with more stringent bootstrapping criteria: changing the 
percentage of cell to be re-clustered from 50-90%, and this analysis resulted in similar cluster 
structure and nucleus membership (Fig. S4D, middle, and Fig. S4E).  Randomizing the Jaccard 
distance matrix prior to principal component analysis and bootstrapped clustering, however, 
yielded no clusters in the dataset (Fig. S4D, right).  Together these analyses suggest that our 
identified clusters represent real and reproducible cell groups.   
Clustering single nuclei:  comparing choice of feature set. We also attempted to cluster 
nuclei using other feature sets besides Jaccard distances among cells (Fig. S4F).  These 
feature sets included:  1) the list of all detected peaks from the entire aggregated dataset 
(236,588 peaks called using Homer findPeaks (12) with -region flag), 2) the list of all RefSeq 
gene TSS regions, extended +/- 10kb (27,021 regions), 3) all 321,184 non-overlapping 10kb 
bins across the human genome, and 4) the list of “GeneBins” defined as the genomic region for 
each gene between the boundaries of midpoints between each RefSeq gene transcribed region. 
For each feature set, we computed counts in regions for each cell, then identified principal 
components, and visualized groupings by tSNE of principal components 2:50 in order to 
observe cell groupings.  For our dataset, Jaccard distances disclosed the qualitatively cleanest 
separation among nuclei, and among clusters (Fig. S4F).  Furthermore a wide range of tSNE 
perplexity values maintained these separations (Fig. S4G). 
 Mapping clusters to transcriptomic cell types:  assimilating epigenetic and transcriptomic 
information.  We wished to map our 2,858 high quality ATAC-seq profiled cells to human brain 
cell types discovered by large-scale RNA-seq studies (8).  To do this we first sought the best 
technique to manufacture gene-level information from the ATAC-seq data, in order to correlate 
with RNA-seq transcript counts.  We tried four techniques: 1) read counts in RefSeq “GeneBins” 
as above, 2) read counts in RefSeq gene bodies, 3) read counts in RefSeg gene TSS regions 
extended +/- 10 kb, and 4) Cicero gene activity scores (23,31).  With these four sets of gene-
level information computed for each nucleus, we mapped nuclei to RNA-seq cell types using as 
the best correlated RNA-seq cluster median gene counts per million (CPM) with each epigenetic 
featureset (using a subset of 831 marker genes), resulting in four distinct mappings for each 
nucleus.   
The 831 marker genes were chosen to be both informative marker genes for RNA-seq 
clustering and to contain abundant epigenetic information.  This was accomplished by using the 
select_markers function with default parameters from the scrattch.hicat R package (7) which 
yielded 2,791 transcriptomic marker genes, which was further filtered by intersecting with the 
top ten percent of genes with the highest summed Cicero gene activity scores across all 2,858 
cells, to yield 831 combined transcriptomic and epigenetic marker genes for mapping.   
The four sets of cellwise mappings yielded four tables of cell type abundances within our 
dataset.  Next, taking the RNA-seq dataset (8) as a true gold standard, we compared the four 
cell type abundance tables with the ‘expected’ cell type abundances, which was calculated as 
the sum of numbers of cells sorted in each sort strategy, times the expected cell type 
frequencies in each sort strategy.  Correlating the four cell type abundance tables with the 
expected abundance table (pearson correlations of log-transformed abundance values plus 
one) revealed that Cicero gene activity scores supply the most dependable gene-level 
information for the purpose of epigenetic to transcriptomic mapping (Fig. S5A).   
Mapping clusters to transcriptomic cell types:  bootstrapping mapping for final mapping 
calls.  Using Cicero gene activity scores, we bootstrapped the cellwise mapping procedure 100 
times with retention of a variable 50-90% of genes each round, and applied the most frequently 
mapped transcriptomic cell type to each single ATAC-seq nucleus.  Then we report the 
percentage of each cluster’s constituent cells mapping to each cell type in Fig. S5B, and 
summed by cell type subclass in Fig. S5D. 
We also performed clusterwise mapping for each of the 27 ATAC-seq clusters using the 
same bootstrapped mapping procedure, except that we aggregated Cicero gene activity scores 
by mean across cells within each cluster prior to mapping.  We report the number of 100 times 
that each cluster is mapped to each cell type in Fig. S5C, and summed by transcriptomic 
subclass in Fig. S5E.   
We observe that clusterwise mapping largely agrees with, but is cleaner than, cellwise 
mapping (compare Fig. S5B and S5C, also S5D and S5E, and S5F); hence we elect clusterwise 
mapping as the final mapping procedure.  Each cell is thus assigned a final mapped 
transcriptomic cell type (shown in Fig. S5C) and cell type subclass (shown in Fig. S5E) as a 
result of its ATAC-seq cluster membership.  For all downstream analyses of peaks in Figures 1-
4, we use aggregations at the cell type subclass level to find peaks.   
Peak calling.  We called peaks on both bulk and aggregated single-nucleus data using 
Homer findPeaks with -region flag (12).  We found this program to be superior to Hotspot (v4), 
MACS2 (26), and SICER (https://home.gwu.edu/~wpeng/Software.htm) to identify small regions 
corresponding to likely enhancers, while still capturing the peak boundaries.  In preliminary 
experiments we observed that Hotspot returned small regions of a constant size (150bp or 
250bp) that did not always align to peak summits, but it was relatively insensitive to read depth.  
MACS2 performed better than hotspot at picking full peak sizes but peak numbers found were 
strongly dependent on read depth.  SICER returned very large regions (median >2kb) that did 
not clearly correspond to visual peaks. Using Homer findPeaks with -region flag, peak sizes are 
median 400-500 bp across subclasses, and we observed only a shallow dependence of 
identified peaks on read depth.   
Identifying transcription factor motifs using chromVAR.  We used chromVAR (13) to 
identify transcription factor motif accessibilities in our nuclei.  Using Homer findPeaks with -
region flag, we called peaks on the aggregation of all single nuclear and bulk libraries (236,588 
peaks), and then resized them to a standard 150bp size with the same center.  We downloaded 
452 transcription factor motifs from JASPAR (using JASPAR2018 R package, 32) and 1,764 
from cisBP (as included in the R package chromVARmotifs, 13), and used chromVAR to 
aggregate and quantify motif accessibilities in all 2,858 single nuclei.  Cell type subclass-
distinguishing motifs across were found by ranking subclass-averaged motif accessibilities by 
standard deviation across subclasses (including DLX1 and NEUROD6, Fig. 2A-B).   
 Global peak characterization by conservation. With peaks called for each subclass, we 
partitioned peaks into 1) TSS-proximal peaks which were 20 kb or less distant from any of 
27,021 RefSeq gene TSS sites, and 2) TSS-distal peaks which were farther than 20 kb from any 
TSS.   
For peak phyloP scores, we used bigWigSummary to lookup phyloP values from 
hg38.phyloP4way.bw.  These files quantify the basepair conservation across four mammals:  
Homo sapiens, Mus musculus, Galeopterus variegatus (Malayan flying lemur), and Tupaia 
chinensis (Chinese tree shrew).   We return ten values distributed across each peak, and 
calculate the maximum mean of eight three-consecutive-value sets.  This is done to find smaller 
regions on the order of 100 bp highly conserved regions within each peak, and yields greater 
deviations between real and random phyloP scores than taking a single peak-wise average 
alone.  We compared peak-wise phyloP scores to those of randomly distributed peak regions 
throughout the genome by subtracting real peak phyloP mean minus random peak phyloP 
mean.   
Identifying transcriptomic cell type matches for methylation data.  Using the dataset of 
Luo et al. (15), we correlated the published mCH gene body marker genes (their Supplementary 
Table 3 containing 1012 human and 1016 mouse methylation marker genes) with cluster-wise 
medians for transcriptomic human cell types identified by Hodge et al. (8) and for mouse cell 
types by Tasic et al. (7).  We calculated Pearson correlation coefficients between normalized 
gene body mCH and RNA-seq clusterwise median FPKM, and assigned the best-correlated 
transcriptomic cell type to each methylation cell type as in Fig. S6.  Specificity of matches was 
calculated as the difference between the best correlation and the second-best correlation.  
Importantly, our transcriptomic cell type assignments agreed with the previously predicted 
subclasses.   
Quantifying ATAC-seq peak overlaps with DMRs.  We first aggregated human DMRs 
from Luo et al. and Lister et al. (14, 15).  For neuron types, we downloaded DMRs and merged 
them using bedtools mergeBed.  For non-neuron types, we downloaded raw fastq files from the 
GEO submission of Lister et al. (14) corresponding to bulk NeuN-negative cells from two human 
replicates (GSM1173774 and GSM1173777), and converted these to allc files using the pipeline 
analysis method of Luo et al. (15).  These allc files were aggregated and used to find DMRs with 
methylpy DMRfind against allc files for all human subclasses from Luo et al., and an outgroup of 
human H1 cells from ENCODE (20).  The same set of bulk non-neuronal DMRs were used for 
comparison to Astrocytes, Oligodendrocytes/OPCs, and Microglia ATAC-seq classes (Fig. 2E-
F). 
 With bed files corresponding to each subclass ATAC-seq peakset and to each subclass 
DMR set, we used bedtools intersectbed to quantify the overlap between peaks and DMRs.  We 
bootstrapped calculation of real peak overlaps 100x by removing 20 percent of peaks each time 
and calculating percentage overlap, and the mean of these 100 measurements is reported.  
Similarly we randomized peak positions throughout the genome 100x using bedtools 
shuffleBed, calculated percentage overlap each time, and the mean of these 100 
measurements is reported.  By definition, disjoint ranges of real versus randomized peak 
overlap percentages established false discovery rate < 0.01.  We also calculated enrichment of 
DMR overlaps for ATAC-seq peaksets, defined as the ratio of real peak-DMR overlap 
percentage to the overlap percentage of randomized peak positions.   
 Mouse to human cross-species comparisons.  We used the sets of subclass-specific 
(uniquely identified in only that subclass) peaks to map between human and mouse subclasses.  
We first mapped subclass-specific mouse peaks to hg38 using liftOver. Then we bootstrapped 
calculation of human peak overlap against all mouse peaks 100x with random retention of 80% 
of human peaks each time, and we took mean of Jaccard similarity coefficients (intersection 
over union) over 100 runs.  In addition, we shuffled genomic peak positions 100x, and 
calculated mean Jaccard similarity coefficients each time.  We report the enrichment of Jaccard 
similarity coefficients as the ratio of the real over random (Fig. 3A).  To visualize set 
intersections in Venn diagram format we display results using all mouse and human peaks (not 
subclass-specific, Fig. 3B).   
For characterization of human conserved and divergent peaks, we start with all human 
peaks and partition to those intersecting (“Conserved”) or not intersecting (“Divergent”) with 
mouse peaks identified within the same orthologous subclass and mapped to hg38 by liftOver.  
To characterize mouse conserved and divergent peaks, we intersect all mouse peaks with 
reciprocal mm10-mapped human peaks.  Then we calculated phyloP scores as above.   
Quantifying repetitive element overlap.  To characterize the repetitive element overlap 
for peaks, we first partitioned mouse and human subclass-specific peaksets to conserved and 
divergent peaks.  Then we calculated the overlap with repetitive genomic elements using hg38 
and mm10 RepeatMasker (v.4.0.5, http://www.repeatmasker.org) files, using a 100x 
bootstrapped overlap and 100x bootstrapped randomization strategy as described above for 
DMR overlap.  We report the enrichment ratio of each real peakset to its position-permuted 
randomized counterpart.  Human L56IT peaks were omitted from this analysis because very few 
of these peaks are both subclass-specific and conserved. 
Cloning enhancers.  Enhancers were manually chosen from ATAC-seq and RNA-seq 
data for cloning by the following criteria:  1) adjacent to known subclass marker gene, and 2) 
specifically accessible peak in only the subclass of interest, and 3) contains region of high 
primary sequence conservation by phyloP score.   
Chosen enhancers were cloned into AAV expression vectors that are derivatives of 
either pscAAV-MCS (Cell Biolabs catalog # VPK-430), including eHGT_019h, eHGT_017h, 
eHGT_022h, eHGT_022m, and eHGT_023h; or pAAV-GFP (Cell Biolabs catalog # VPK-410), 
including eHGT_078h, eHGT_058h, eHGT_060h, and hDLXI56i (24, 25).  Enhancers were 
inserted by standard Gibson assembly approaches, upstream of a minimal beta-globin promoter 
and SYFP2, a brighter EGFP alternative that is well tolerated in neurons (34).  NEB Stable cells 
(New England Biolabs # C3040I) were used for transformations and cultured at 32 degrees.  
scAAV plasmids were monitored by restriction analysis and Sanger sequencing for occasional 
(~10%) recombination of the left ITR; this recombination was not observed for rAAV plasmids.   
Virus production.  Enhancer AAV plasmids were maxi-prepped and transfected with PEI 
Max 40K (Polysciences Inc., catalog # 24765-1) into one 15 cm plate of AAV-293 cells (Cell 
Biolabs catalog # AAV-100), along with helper plasmid pHelper (Cell BioLabs) and PHP.eB 
rep/cap packaging plasmid (24), with a total mass of 150 μg PEI Max 40K, 30 μg pHelper, 15 μg 
rep/cap plasmid, and 15 μg enhancer-AAV vector.  The next day medium was changed to 1% 
FBS, and then after 5 days cells and supernatant were harvested and AAV particles released by 
three freeze-thaw cycles.  Lysate was treated with benzonase after freeze thaw to degrade free 
DNA (2 μL benzonase, 30 min at 37 degrees, MilliporeSigma catalog # E8263-25KU), and then 
cell debris was precleared with low-speed spin (1500g 10 min), and finally the crude virus was 
concentrated over a 100 kDa molecular weight cutoff Centricon column (MilliporeSigma catalog 
# Z648043) to a final volume of ~150 μL.  For highly purified large-scale preps this protocol was 
altered so that ten plates were transfected and harvested together at 3 days after transfection, 
and then the crude virus was purified by iodixanol gradient centrifugation.   
Mouse virus testing.  Mice were retro-orbitally injected at P42-P49 with 10 μL 
(approximately 1E11 genome copies) of crude virus prep diluted with 100 μL PBS, then 
sacrificed at 18-28 days post infection.  For live epifluorescence, mice were perfused with 
ACSF.7 and live 350 μm physiology sections were cut with a compresstome from one 
hemisphere to analyze reporter expression.  For antibody staining the other hemisphere was 
drop-fixed in 4% PFA in PBS for 4-6 hours at 4 degrees, then cryoprotected in 30% sucrose in 
PBS 48-72 hours, then embedded in OCT for 3 hours at room temperature, then frozen on dry 
ice and sectioned at 10 μm thickness, prior to antibody stain using standard practice.  Primary 
antibodies used were chicken anti-GFP (Aves # GFP-1020), rabbit anti-Parvalbumin (Swant # 
PV27), rabbit anti-Somatostatin (Peninsula Biolabs # T-4547), rabbit anti-VIP (BosterBio # 
RP1108), and mouse anti-RFP (abcam # ab65856) to detect mCherry from Gad2-T2a-NLS-
mCherry mice (35).  Secondary antibodies were 488-, 555-, and 647-conjugated secondary 
antibodies from ThermoFisher Scientific.  To infer LAMP5+ character by immunostaining, we 
looked for Gad2-T2a-NLS-mCherry+ cells that were also negative for a stacked stain of VIP and 
Somatostatin and Parvalbumin.  Single-cell RNA-seq from the mouse visual cortex was 
accomplished as described previously (6,7). 
Human virus testing.  Temporal cortex samples obtained from neurosurgical resection 
were bubbled in cold ACSF.7 and kept sterile throughout processing.  Blocks of tissue were 
sliced at 350 μm thickness and white matter and pial membranes were dissected away.  
Typically all layers are represented in each cortical slice.  Slices then underwent warm recovery 
(bubbled ACSF.7 at 30 degrees for 15 minutes) followed by reintroduction of sodium (bubbled 
ACSF.8 at room temperature for 30 minutes, recipe below, 36).  Slices were then plated at the 
gas interface on Millicell PTFE cell culture inserts (MilliporeSigma # PICM03050) in a 6-well dish 
on 1 mL of Slice Culture Medium (recipe below).  After 30 minutes, slices were infected by direct 
application of high-titer AAV2/PHP.eB viral prep to the surface of the slice, 1 μL per slice. Slice 
culture medium was replenished every 2 days and reporter expression was monitored.   
Single cell RNA-seq was accomplished on human virus-infected neurons by 1 hr 
digestion at 30 degrees in carbogenated ACSF.1/trehalose + blockers + papain (all recipes 
below), followed by gentle trituration in Low-BSA Quench buffer, shallow spin gradient 
centrifugation (100g 10 minutes at room temperature) into High-BSA Quench buffer, and 
resuspension into Cell Resuspension Buffer.  We also employed Myelin Bead Removal Kit II 
(Miltenyi catalog # 130-096-733) at 1/20 to remove myelin debris, and PE-anti CD9 clone 
eBioSN4 (Thermo Fisher catalog # 12-0098-42) at 1/40 to sort away contaminating glial cells.  
Then we sorted single SYFP2+ labeled human neurons for sequencing using SMARTer V4 as 
previously described (6, 7).  To map single cells to the transcriptomic databases, we trained a 
nearest centroid classifier on cell type labels using human and mouse V1 scRNA-seq cluster 
labels (7, 8), employing informative marker genes chosen by the select.markers function in 
scrattch.hicat (7).  Intermediate-mapping cells are represented as nodes on the cluster 
dendrogram.   
Inferring GWAS-cell subclass associations.  We used linkage disequilibrium score 
regression (LDSC, 17, 18) to partition heritability of various brain conditions to regions 
associated with accessible chromatin in eleven human cortical cell subclasses, whose peaks 
are partitioned into Conserved and Divergent subsets.  As outgroup comparators, we also 
investigated heritability associated with outgroup populations of human keratinocytes 
downloaded from ENCODE.   
We downloaded summary statistics from 21 GWAS studies including expected brain-
related (schizophrenia, major depressive disorder, autism spectrum disorder, ADHD, 
Alzheimer’s disease, Tourette’s syndrome, bipolar disorder, eating disorder, obsessive-
compulsive disorder, loneliness, BMI, PTSD) and expected non-brain-related diseases (Crohn’s 
disease and asthma) from the PGC and EMBL/EBI GWAS repositories (37-57).  We excluded 
studies with log10( N * h
2 ) < 3.6, where N is number of patients in the study and h2 represents 
the sum of heritability across SNPs within the study, the effective power of the study (18).  This 
exclusion removed asthma (40, log10( N * h
2 ) = 3.5, PTSD (41, log10( N * h
2 ) = 2.9), eating 
disorder (42, log10( N * h
2 ) = 3.5), loneliness (43, log10( N * h
2 ) = 3.3), obsessive-compulsive 
disorder (44, log10( N * h
2 ) = 3.5), and one major depressive disorder study (48, log10( N * h
2 ) = 
3.3).  All 15 included studies were performed on a European descent population. Within these 
datasets, we confined analysis to 1,389,227 high-confidence SNPs present in the HapMap3 list, 
and using linkage disequilibrium maps from the 1000 Genomes Project European descent 
individuals, we analyzed the trait and disease enrichments of cell subclass-associated 
chromatin along with the LDSC baseline model LDv2.0 with 75 enumerated genomic feature 
categories.  For statistical testing to identify significant enrichments we use Bonferroni multiple 
hypothesis testing correction of LDSC’s block jackknife-estimated p-values, as previously 
suggested (21).  This correction is 0.05 / 345 disease/subclass combinations = 1.45e-4 
significance cutoff in Fig. 3D, and we similarly use 180 and 150 tests in Fig. S8A and S8B.     
 
 
Buffer Recipes.   
Proteinase K Cleanup Buffer 
EDTA     50 mM 
Sodium chloride    5 mM 
Sodium dodecyl sulfate   1.25% (w/v) 
Proteinase K (Qiagen # 19131)  5 mg/mL 
 
Nuclei Isolation Medium 
Sucrose     250 mM 
Potassium chloride   25 mM 
Magnesium chloride   5 mM 
Tris-HCl     10 mM 
pH to 8.0 and sterile filter.  Store refrigerated. 
 
Homogenization Buffer 
10 mL Nuclei Isolation Medium 
0.1% (w/v) Triton X-100 
One pellet Roche Mini cOmplete EDTA-free (Sigma catalog # 4693159001) 
Prepare fresh on day of experiment. 
 
Blocking Buffer 
PBS 
0.5% (w/v) BSA (catalog # A2058 from Millipore Sigma) 
0.1% (w/v) Triton X-100 
 
ACSF.7  
HEPES     20 mM 
Sodium Pyruvate    3 mM 
Taurine     10 μM 
Thiourea     2 mM 
D-(+)-glucose    25 mM 
Myo-inositol    3 mM 
Sodium bicarbonate   30 mM 
Calcium chloride dihydrate  0.5 mM  
Magnesium sulfate   10 mM 
Potassium chloride   2.5 mM 
Monosodium Phosphate   1.25 mM 
HCl     92 mM 
N-methyl-D-(+)-glucamine  92 mM 
L-ascorbic acid    5.0 mM 
N-acetyl-L-cysteine   12 mM 
Adjust pH to 7.3-7.4 with HCl, then adjust osmolarity to 295-305 (Wescor Inc VAPRO model 
# 5600). 
Sterile filter, and then make 100mL aliquots and freeze them.  The thawed aliquot keeps 2-3 
months at 4 degrees; discard if a yellow discoloration is observed.  Bubble with carbogen at 
least 10-15 minutes before use, and continuously while in use.   
 
ACSF.8  
HEPES     20 mM 
Sodium Pyruvate    3 mM 
Taurine     10 μM 
Thiourea     2 mM 
D-(+)-glucose    25 mM 
Myo-inositol    3 mM 
Sodium bicarbonate   30 mM 
Calcium chloride dihydrate  2.0 mM  
Magnesium sulfate   2.0 mM 
Potassium chloride   2.5 mM 
Monosodium Phosphate   1.25 mM 
Sodium chloride    92 mM 
L-ascorbic acid    5.0 mM 
N-acetyl-L-cysteine   12 mM 
Adjust pH to 7.3-7.4 with HCl, then adjust osmolarity to 295-305. 
Sterile filter, and then make 100mL aliquots and freeze them.  The thawed aliquot keeps 2-3 
months at 4 degrees; discard if a yellow discoloration is observed.  Bubble with carbogen at 
least 10-15 minutes before use, and continuously while in use.   
 Slice Culture Medium  
MEM Eagle medium powder  1680 mg (MilliporeSigma catalog # M4642) 
L-ascorbic acid powder   36 mg 
CaCl2, 2.0 M    100 μL 
MgSO4, 2.0 M    200 μL  
HEPES, 1.0 M    6.0 mL 
Sodium bicarbonate, 893 mM  3.36 mL 
D-(+)-glucose, 1.11 M   2.25 mL 
Pen/Strep 100x (5k U/mL)  1.0 mL  (Thermo catalog # 15070063) 
Tris base, 1.0 M    260 μL 
GlutaMAX 200 mM   0.5 mL  (Thermo catalog # 35050061)  
Bovine Pancreas Insulin, 10 mg/mL 20 μL  (MilliporeSigma catalog # I0516) 
Heat-inactivated horse serum  40 mL  (Thermo catalog # 26050088) 
Deionized water    to 250 mL 
Adjust pH to 7.3-7.4 with HCl, then adjust osmolarity to 300-305.  Sterile filter and store 
refrigerated for up to 1-2 months. 
 
ACSF.1/trehalose  
HEPES     20 mM 
Sodium Pyruvate    3 mM 
Taurine     10 μM 
Thiourea     2 mM 
D-(+)-glucose    25 mM 
Myo-inositol    3 mM 
Sodium bicarbonate   25 mM 
Calcium chloride dihydrate  0.5 mM  
Magnesium sulfate   10 mM 
Potassium chloride   2.5 mM 
Monosodium Phosphate   1.25 mM 
Trehalose dihydrate   132 mM 
HCl     2.9 mM 
N-methyl-D-(+)-glucamine  30 mM 
L-ascorbic acid    5.0 mM 
N-acetyl-L-cysteine   12 mM 
Adjust pH to 7.3-7.4 with HCl  and adjust osmolarity to 295-305. 
Sterile filter, and then make 100mL aliquots and freeze them.  The thawed aliquot keeps 2-3 
months at 4 degrees. 
 
ACSF.1/trehalose + blockers:  
50 mL ACSF.1/trehalose  
50 μL 100 μM TTX (final 0.1 μM) 
100 μL 25 mM DL-AP5 (final 50 μM) 
15 μL 60 mM DNQX (final 20 μM) 
5 μL 100 mM (+)-MK801 (final 10 μM) 
 
ACSF.1/trehalose + blockers + papain: 
15 mL ACSF.1/trehalose + blockers 
One vial Worthington PAP2 reagent (150 U, final 10U/mL) 
15 μL 10kU/mL DNase I (Roche) 
     
Low-BSA Quench buffer  
15 mL ACSF.1/trehalose + blockers 
15 μL 10kU/mL DNase I (Roche) 
150 μL 20% BSA dissolved in water (final conc 2 mg/mL) 
150 μL 10 mg/mL ovomucoid inhibitor (Sigma T9253, final concentration 0.1 mg/mL) 
 
High-BSA Quench buffer  
15 mL ACSF.1/trehalose + blockers 
15 μL 10kU/mL DNase I (Roche) 
750 μL 20% BSA dissolved in water (final concentration 10 mg/mL) 
150 μL 10 mg/mL ovomucoid inhibitor (Sigma T9253, final concentration 0.1 mg/mL) 
 
ACSF.1/trehalose + EDTA 
HEPES     20 mM 
Sodium Pyruvate    3 mM 
Taurine     10 μM 
Thiourea     2 mM 
D-(+)-glucose    25 mM 
Myo-inositol    3 mM 
Sodium bicarbonate   25 mM 
Potasium chloride    2.5 mM 
Monosodium Phosphate   1.25 mM 
Trehalose     132 mM 
HCl     2.9 mM 
EDTA     0.25 mM 
N-methyl-D-(+)-glucamine  30 mM 
L-ascorbic acid    5.0 mM 
N-acetyl-L-cysteine   12 mM 
Adjust pH to 7.3-7.4 with HCl and adjust osmolarity to 295-305. 
Sterile filter, and then make 100mL aliquots and freeze them (-20).  The thawed aliquot 
keeps 2-3 months at 4 degrees. 
 
Cell Resuspension Buffer 
50 mL ACSF.1/trehalose + EDTA 
50 μL 100 μM TTX (final 0.1 μM) 
100 μL 25 mM DL-AP5 (final 50 μM) 
15 μL 60 mM DNQX (final 20 μM) 
5 μL 100 mM (+)-MK801 (final 10 μM) 
150 μL 20% BSA dissolved in water (final concentration 2 mg/mL) 
1 μg/mL 4’-diamino-phenylindazole (DAPI) 
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Supplementary Figure 1:  Profiling chromatin accessibility across multiple human 
temporal cortex tissue samples. 
A)  Summary table of 17 human neurosurgical specimens used for chromatin accessibility 
profiling experiments by ATAC-seq.  Deidentified specimen codes are given along with type of 
ATAC-seq experiments performed (Bulk or Single-cell), age, gender, patient disease requiring 
surgery, and region of tissue harvested.   
B)  Flow cytometry performed in the course of sorting nuclei demonstrates that tumor and 
epilepsy cases display qualitatively similar-staining nuclei, and quantitatively similar relative 
proportions of neuronal nuclei within the sample.  On top, example flow plots from PE-anti NeuN 
and NeuroTrace 500/525-stained layer 5 nuclei from one epilepsy and one tumor case are 
shown.  On bottom, percentages of nuclei labeled with anti NeuN antibody from six dissected 
layers of cortex, from 12 specimens. Four specimens were not analyzed in this way, and one 
specimen (H18.03.005) was omitted from this analysis because of poor staining due to analysis 
after an overnight incubation. 
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Supplementary Figure 2:  Bulk ATAC-seq data demonstrates differentially accessible 
chromatin elements around known marker genes, and in novel genomic regions. 
A)  snRNA-seq data (from Hodge et al., 8), aggregated into pseudo-bulk profiles by weighted 
averages of gene CPM medians for 75 transcriptomic clusters. We assigned weights by their 
frequencies within the eight sort strategies, and the heatmap is scaled by z-score within each 
column (gene).  As a result, relative expressions of eight sort strategy-specifc marker genes are 
displayed.   
B)  Example sort strategy-specific peaks proximal to (< 50kb distance to gene body) these eight 
sort strategy-specific transcriptomic marker genes.  Pileups indicate aggregated data across five 
independent experiments.  In B and E, dashed lines indicate introns, thick lines indicate exons, 
and arrows indicate direction towards proximal marker gene, within a 2 kb genomic window.  
Yellow highlights demarcate sort strategy-specific chromatin accessibility peaks.  
C)  We used DiffBind (27) to identify 72216 peaks that were differentially accessible among any 
pairwise comparison of sort strategies (FDR 0.01).  We then used read counts within those 
72216 differentially accessible peaks to cluster samples using a correlation distance matrix, 
which revealed separate groupings of non-neuronal samples, and upper- and lower-layer 
neuronal samples.  One sample was omitted from this analysis (H17.03.009 L1 NeuN+) 
because this sample appeared intermediate between NeuN+ and NeuN- cells, suggesting a 
failed sort.   
D)  Number of peaks differentiating each pairwise sample contrast.  Many peaks distinguish 
neurons and non-neurons, fewer peaks distinguish upper- and lower- layer neurons, and even 
fewer peaks distinguish neurons from adjacent layers.   
E)  Example sort strategy-specific peaks resulting from pairwise DiffBind differential peak 
analysis.  These peaks were found in novel genomic regions (not proximal to known marker 
genes), and closest genes are shown.   
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Supplementary Figure 3:  High quality single cell ATAC-seq libraries. 
A) We calculated quality control metrics for bulk (left), all 3660 single nuclei (middle), and 2858 
quality-filtered single nuclei (right).  These metrics were ENCODE frontal cortex DNaseI 
hypersensitivity peak overlap percentage (x axis), and TSS enrichment score (y axis).  We 
filtered out poor-quality single cells with TSS enrichment score < 4 AND ENCODE overlap < 
15%, OR < 10000 unique mapped reads per nucleus.  Plots are colored by sort strategy (top) or 
by specimen (bottom).   We observe no obvious grouping of cell qualities by sort strategy or 
specimen.  Furthermore, filtered cells display high quality metrics, similar to bulk samples.  
B)  We calculated summary sequencing statistics for 2858 quality-filtered single cells.  Black 
lines represent mean across all 2858 nuclei.  For total reads, six outlier nuclei with very high 
read counts were omitted from the graph. 
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Supplementary Figure 4:  High confidence clustering for single cell ATAC-seq data. 
A)  We used a histogram to visualize the percentages of variance explained by each principal 
component of the Jaccard single cell distance matrix.  Thirty principal components explain 
substantial variance within the dataset.   
B)  Correlating the first 5 principal components with quality metrics demonstrates that PC1 is 
uniquely negatively correlated with ENCODE overlap quality, suggesting its omission.   
C)  We visualized single cells in PC1/PC2 space and colored by clusters (left).  Clusters 
grouped within three main lobes of cells separated by PC2, but PC1 spreads the three main 
lobes without segregating clusters.  Single cells were also colored by ENCODE overlap 
percentage, which is strongly negatively correlated with PC1.   
D)  We used tSNE to visualize cells using either principal components 2 to 30 (left) or 1 to 30 
(right).  PCs 2 to 30 permit clear cell groupings with no ENCODE overlap gradient, whereas 
PCs 1 to 30 result in blurred cluster separations with a gradient of ENCODE overlap apparent 
among the cell clusters.   
E)  We performed bootstrapped iterative clustering to identify reproducible groups of cells.  
From the 2858 x 29 matrix of cells x principal component scores, we subsampled to either a 
constant 80% of cells (left) or a variable 50-90% of cells (middle), and calculated clusters using 
Jaccard-Louvain clustering (7), which was repeated 200 times.  On right we used a shuffled 
Jaccard distance matrix as input to PCA.  Heatmaps display the frequency of coclustering 
among cells, which reveals similar cluster structure with both bootstrapping techniques, but no 
clusters observed with shuffled input data.  The constant 80% bootstrapping coclustering matrix 
was used as input into Euclidean distance clustering, which yielded the final 27 clusters by 
cutting the tree to the major blocks of coclustering cells.  Cell order is not matched across the 
three plots. 
F)  Cluster memberships resulting from constant 80% bootstrapping and from variable 50-90% 
bootstrapping largely agree.   
G)  We computed read counts in five different feature sets (see Methods) for the 2858 cells, 
input them all to PCA, and used tSNE to visualize cell groupings for PCs 2:50 (or 2:30 for 
Jaccard distances).  We find that pairwise Jaccard distances distinguish groups of cells better 
than the other four feature sets.  Cluster colors are applied in both (G) and (H).   
H)  We used five different perplexity values for tSNE visualization, which shows cell cluster 
groupings are evident at a wide range of perplexity values but perplexity of 25 is preferred.   
I)  Nuclei that were processed from tumor specimens cocluster with nuclei that were processed 
from epilepsy specimens, and we do not observe disease-specific clusters.  
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Supplementary Figure 5:  Mapping ATAC-seq clusters to RNA-seq cell types. 
A)  We wished to determine the optimal method to compute gene-level information from ATAC-
seq data for the purpose of mapping ATAC-seq clusters to RNA-seq cell types.  First we 
computed the expected abundances of each of the 75 transcriptomic cell types (identified by 
Hodge et al., 8) within our dataset, accounting for the cell numbers sorted as well as 
frequencies of different cell types within each sort strategy.  Second we computed gene-level 
information from 10000 fragment-downsampled single cell ATAC-seq libraries according to four 
techniques:  far left: read counts in gene bins, middle left: read counts in gene bodies, middle 
right: read counts in 10kb-extended TSS regions, and far right: Cicero gene activity scores.  
Third we examined the correlations between RNA-seq cluster medians and epigenetic gene-
level information, for a set of 831 RNA-seq marker genes that also are within the top ten percent 
of genes for Cicero gene activity scores, and matched each ATAC-seq cell to its highest 
correlated RNA-seq cluster (greatest Spearman correlation statistic).  Finally we compared the 
observed abundances of mapped cell abundances to the expected abundances, and found that 
Cicero gene activity scores yielded mappings that correlated most with expectation.  Scatter 
plots demonstrate the expected versus observed abundances for each of the 75 transcriptomic 
cell types within our dataset, using the four featuresets for mapping.  Correlation values are 
Pearson correlation statistics between log-transformed expected and observed abundances 
plus one.   
B)  We bootstrapped the mapping of single cells to RNA-seq clusters using Cicero gene activity 
scores for 831 RNA-seq and Cicero marker genes.  Each round, we retained 50-90% of the 
genes and computed best mapping, and we repeated this process 100 times.  We assigned 
each cell its most frequently mapped transcriptomic type, and we report the frequencies of cell 
mappings within each of the 27 ATAC-seq clusters.      
C)  We bootstrapped mapping of ATAC-seq clusters to transcriptomic cell types as in B, but 
here we used the cluster-wise means of Cicero gene activity scores for that cluster’s component 
cells.  We report the number of times that each cluster mapped to each cell type.  This plot 
represents the final mapped cell type as the most frequent cell type mapping for each cluster. 
D)  We summed across transcriptomic cell types within subclasses for cellwise mapping (in B), 
to yield cellwise mapping to subclasses.   
E)  We summed across transcriptomic cell types within subclasses for clusterwise mapping (C), 
to yield clusterwise mapping to subclasses.  This plot represents the final mapped subclass 
assigned as the most frequent mapping for each cluster, and these subclass identities are used 
for the pileups and calculations in Figs 1-4.  
F)  We tabulated the subclass mapping for all cells using four different mapping techniques.  
Overall, most cells are identically mapped to the same subclass with most of the techniques, 
with especially good agreement between both clusterwise mapping techniques. 
G)  We calculated Spearman correlation coefficients between RNA-seq and ATAC-seq dataset 
layerwise distributions for the 11 subclasses.  Most of the subclasses are observed in similar 
layer distributions in both datasets.   
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Supplementary Figure 6:  Mapping methylation cell types to RNA-seq cell types.  We took 
methylation cell types from Luo et al. (15), and RNA-seq cell types from Hodge et al. (human, 8) 
or from Tasic et al. (mouse, 7, focusing on V1 excitatory transcriptomic cell types only).  We 
correlated mCH methylation within methylation cell type marker gene bodies, with cluster 
median CPM for RNA-seq cell types.  The RNA-seq cell type having the strongest anti-
correlation between mCH levels and CPM was assigned as the best match to the methylation 
cell type (and vice-versa from methylation to RNA-seq).  This analysis was repeated for both 
human (A) and mouse (B) independently.  Specificity is defined as the difference between the 
best correlation and the second-best correlation among all the competing choices.  For analysis 
in Figs 2 and S8, the methylation cell types were aggregated into transcriptomically defined 
subclasses according to their best matches shown here, with the following exception that mL4 
methylation cell type was assigned as mL4 transcriptomic subclass even though it maps best to 
a mL56IT transcriptomic cell type.   
 
 
AB
All 
repetitive
elements
DNA
transposons
LINE
elements
LTR
elements
Satellite
DNA
Simple
repeats
SINE
elements
All 
repetitive
elements
DNA
transposons
LINE
elements
LTR
elements
Satellite
DNA
Simple
repeats
SINE
elements
*** ***
*****
**
** *** ***
ns
ns
ns
ns
ns
***
0.0
0.5
1.0
1.5
2.0
Cons. Div. Cons. Div. Cons. Div. Cons. Div. Cons. Div. Cons. Div. Cons. Div.
Cons. Div. Cons. Div. Cons. Div. Cons. Div. Cons. Div. Cons. Div. Cons. Div.
H
u
m
a
n
 p
e
a
k
 e
n
ri
c
h
m
e
n
t 
ra
ti
o
0.0
0.5
1.5
1.0
2.0
M
o
u
s
e
 p
e
a
k
 e
n
ri
c
h
m
e
n
t 
ra
ti
o Astro
OligoOPC
Micro
L23
L4
L56IT
DL
LAMP5
VIP
SST
PVALB
No enrichment
over random
Supplementary Figure 7:  Compared to conserved peaks, divergent peaks have greater 
overlap with multiple classes of repetitive genomic elements.  We calculated the 
percentage of ATAC-seq peaks that overlapped with multiple classes of repetitive elements, and 
report the enrichment ratio of those real peaks’ overlaps to the overlaps for corresponding 
random position-permuted genomic positions.  We performed this analysis on subclass-specific 
peaksets from both human (A) and mouse (B).  An enrichment value of 1.0 corresponds to no 
fold change between real and random peaks.  Black bars represent the mean across the eleven 
neocortical cell subclasses.  We performed significance testing using heteroscedastic t-tests:  
*** p < 0.001, ** p < 0.01, ns not significant.  Human all elements  t = 5.2, df = 14.5; human DNA 
transposons t = 3.4, df = 14.8; human LINE t = 5.3, df = 18.3; human SINE t = 3.8, df = 18.8; 
human LTR t = 6.1, df = 18.3; human satellite t = 0.2, df = 12.4; human simple t = 1.6, df = 10.1; 
mouse all elements  t = 3.7, df = 16.9; mouse DNA transposons t = 1.3, df = 12.7; mouse LINE t 
= 5.2, df = 18.5; mouse SINE t = 5.2, df = 18.0; mouse LTR t = 6.1, df = 17.5; mouse satellite t = 
1.6, df = 9.7; mouse simple t = 0.3, df = 19.0. 
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Supplementary Figure 8:  ATAC-seq peaks and DMRs yield similar disease associations 
with multiple human neocortical neuron subclasses.  Associations between genome-wide 
association study diseases and class-specific peaksets show that multiple brain diseases are 
linked with multiple neuron classes.  These widespread associations are observed with both 
ATAC-seq peaks (A) and DMRs (B, DMR data from Lister et al. (14) and Luo et al. (15)).  
Strongest associations are seen for Alzheimer’s disease in microglia, and significant 
associations are seen for educational attainment and schizophrenia across multiple neuronal 
classes.  Only weak non-significant associations are seen between brain diseases and outgroup 
cells (Keratinocytes and H1), as well as between and the outgroup disease (Crohn’s disease) 
and neuronal subclasses.  Enrichments are defined as the ratio of the proportion of heritability 
contained by that peakset’s linked SNPs, to the proportion of that peakset’s linked SNPs, as 
calculated by LDSC (17, 18).  Red outlines demonstrate significant associations after 
performing Bonferroni correction for multiple hypothesis testing (180 tests for ATAC-seq peaks 
and 150 tests for DMRs).   
  
